FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2564120773> ?p ?o ?g. }

• W2564120773 endingPage "491" @default.
• W2564120773 startingPage "486" @default.
• W2564120773 abstract "Ceftaroline fosamil has recently received US Food and Drug Administration approval for treatment of acute bacterial skin/skin structure infections (SSSIs), including those caused by methicillin-resistant Staphylococcus aureus and community-acquired bacterial pneumonia for pediatric patients ≥2 months old. We evaluated the potency and spectrum of ceftaroline and comparators when tested against community-acquired respiratory tract infection (CARTI) and SSSI pathogens from pediatric patients. A total of 3141 consecutive, unique pediatric patient isolates of clinical significance (1460 CARTI and 1681 SSSI isolates) were collected from 29 US medical centers and tested for susceptibility to ceftaroline and comparators by broth microdilution methods. The organism collection included Streptococcus pneumoniae (n = 754), Haemophilus influenzae (487), S. aureus (1399), β-hemolytic streptococci (214), Enterobacteriaceae (112), Pseudomonas aeruginosa (58), Klebsiella spp. (39), Escherichia coli (26) and miscellaneous other bacteria (52). Susceptibility results were analyzed according to patient age as follows: ≤1, 2–5, 6–12 and 13–17 years old. Overall, 99%–100% of Gram-positive isolates and H. influenzae were susceptible to ceftaroline according to Clinical and Laboratory Standards Institute clinical breakpoint criteria. Ceftaroline exhibited potent in vitro activity against bacterial pathogens from CARTI and SSSI recently (2012–2014) collected from pediatric patients in US medical centers. Ceftaroline was particularly active against methicillin-resistant S. aureus from SSSI ([minimum inhibitory concentration for 50% and 90% of isolates (MIC50/90,)] and ceftriaxone-nonsusceptible isolates of S. pneumoniae from CARTI (MIC50/90, 0.25/0.5 μg/mL; 98.3% susceptible)." @default.
• W2564120773 created "2017-01-06" @default.
• W2564120773 creator A5006715126 @default.
• W2564120773 creator A5008542312 @default.
• W2564120773 creator A5026620873 @default.
• W2564120773 creator A5028081249 @default.
• W2564120773 creator A5028739024 @default.
• W2564120773 creator A5041157580 @default.
• W2564120773 date "2017-05-01" @default.
• W2564120773 modified "2023-09-28" @default.
• W2564120773 title "Ceftaroline Activity Tested Against Bacterial Isolates Causing Community-acquired Respiratory Tract Infections and Skin and Skin Structure Infections in Pediatric Patients From United States Hospitals" @default.
• W2564120773 cites W1908523441 @default.
• W2564120773 cites W2028263673 @default.
• W2564120773 cites W2031570656 @default.
• W2564120773 cites W2035275497 @default.
• W2564120773 cites W2049461448 @default.
• W2564120773 cites W2063772284 @default.
• W2564120773 cites W2065590100 @default.
• W2564120773 cites W2101562941 @default.
• W2564120773 cites W2115771487 @default.
• W2564120773 cites W2116581803 @default.
• W2564120773 cites W2119531132 @default.
• W2564120773 cites W2125066910 @default.
• W2564120773 cites W2149296540 @default.
• W2564120773 cites W2154648100 @default.
• W2564120773 cites W2157774744 @default.
• W2564120773 cites W2314729869 @default.
• W2564120773 cites W2323066673 @default.
• W2564120773 doi "https://doi.org/10.1097/inf.0000000000001477" @default.
• W2564120773 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28403050" @default.
• W2564120773 hasPublicationYear "2017" @default.
• W2564120773 type Work @default.
• W2564120773 sameAs 2564120773 @default.
• W2564120773 citedByCount "19" @default.
• W2564120773 countsByYear W25641207732017 @default.
• W2564120773 countsByYear W25641207732018 @default.
• W2564120773 countsByYear W25641207732019 @default.
• W2564120773 countsByYear W25641207732020 @default.
• W2564120773 countsByYear W25641207732021 @default.
• W2564120773 countsByYear W25641207732022 @default.
• W2564120773 countsByYear W25641207732023 @default.
• W2564120773 crossrefType "journal-article" @default.
• W2564120773 hasAuthorship W2564120773A5006715126 @default.
• W2564120773 hasAuthorship W2564120773A5008542312 @default.
• W2564120773 hasAuthorship W2564120773A5026620873 @default.
• W2564120773 hasAuthorship W2564120773A5028081249 @default.
• W2564120773 hasAuthorship W2564120773A5028739024 @default.
• W2564120773 hasAuthorship W2564120773A5041157580 @default.
• W2564120773 hasConcept C126322002 @default.
• W2564120773 hasConcept C176947019 @default.
• W2564120773 hasConcept C2776012195 @default.
• W2564120773 hasConcept C2776315533 @default.
• W2564120773 hasConcept C2776345407 @default.
• W2564120773 hasConcept C2776551000 @default.
• W2564120773 hasConcept C2776925733 @default.
• W2564120773 hasConcept C2777637488 @default.
• W2564120773 hasConcept C2777914695 @default.
• W2564120773 hasConcept C2779489039 @default.
• W2564120773 hasConcept C2780950330 @default.
• W2564120773 hasConcept C2781253189 @default.
• W2564120773 hasConcept C501593827 @default.
• W2564120773 hasConcept C523546767 @default.
• W2564120773 hasConcept C534529494 @default.
• W2564120773 hasConcept C54355233 @default.
• W2564120773 hasConcept C64778159 @default.
• W2564120773 hasConcept C71924100 @default.
• W2564120773 hasConcept C86803240 @default.
• W2564120773 hasConcept C89423630 @default.
• W2564120773 hasConceptScore W2564120773C126322002 @default.
• W2564120773 hasConceptScore W2564120773C176947019 @default.
• W2564120773 hasConceptScore W2564120773C2776012195 @default.
• W2564120773 hasConceptScore W2564120773C2776315533 @default.
• W2564120773 hasConceptScore W2564120773C2776345407 @default.
• W2564120773 hasConceptScore W2564120773C2776551000 @default.
• W2564120773 hasConceptScore W2564120773C2776925733 @default.
• W2564120773 hasConceptScore W2564120773C2777637488 @default.
• W2564120773 hasConceptScore W2564120773C2777914695 @default.
• W2564120773 hasConceptScore W2564120773C2779489039 @default.
• W2564120773 hasConceptScore W2564120773C2780950330 @default.
• W2564120773 hasConceptScore W2564120773C2781253189 @default.
• W2564120773 hasConceptScore W2564120773C501593827 @default.
• W2564120773 hasConceptScore W2564120773C523546767 @default.
• W2564120773 hasConceptScore W2564120773C534529494 @default.
• W2564120773 hasConceptScore W2564120773C54355233 @default.
• W2564120773 hasConceptScore W2564120773C64778159 @default.
• W2564120773 hasConceptScore W2564120773C71924100 @default.
• W2564120773 hasConceptScore W2564120773C86803240 @default.
• W2564120773 hasConceptScore W2564120773C89423630 @default.
• W2564120773 hasIssue "5" @default.
• W2564120773 hasLocation W25641207731 @default.
• W2564120773 hasLocation W25641207732 @default.
• W2564120773 hasOpenAccess W2564120773 @default.
• W2564120773 hasPrimaryLocation W25641207731 @default.
• W2564120773 hasRelatedWork W1970045021 @default.
• W2564120773 hasRelatedWork W2045258580 @default.
• W2564120773 hasRelatedWork W2058341983 @default.
• W2564120773 hasRelatedWork W2082770639 @default.
• W2564120773 hasRelatedWork W2082877365 @default.

• next